Search Results - "Klatte, Derk C. F."

Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer by Bogdanski, Aleksander M., van Hooft, Jeanin E., Boekestijn, Bas, Bonsing, Bert A., Wasser, Martin N. J. M., Klatte, Derk C. F., van Leerdam, Monique E.

“…Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths and is associated with a poor prognosis. The majority of these cancers are…”
Get full text

Hereditary pancreatic cancer by Klatte, Derk C.F., Wallace, Michael B., Löhr, Matthias, Bruno, Marco J., van Leerdam, Monique E.

“…Pancreatic cancer is one of the deadliest malignancies. Therefore, there is an urgent need to detect pancreatic cancer in an earlier stage to improve outcomes…”
Get full text

Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up by Klatte, Derk C F, Boekestijn, Bas, Wasser, Martin N J M, Feshtali Shahbazi, Shirin, Ibrahim, Isaura S, Mieog, J Sven D, Luelmo, Saskia A C, Morreau, Hans, Potjer, Thomas P, Inderson, Akin, Boonstra, Jurjen J, Dekker, Friedo W, Vasen, Hans F A, van Hooft, Jeanin E, Bonsing, Bert A, van Leerdam, Monique E

“…Pancreatic cancer surveillance in high-risk individuals may lead to detection of pancreatic ductal adenocarcinoma (PDAC) at an earlier stage and with improved…”
Get full text

Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis by Klatte, Derk C.F., Boekestijn, Bas, Onnekink, Anke M., Dekker, Friedo W., van der Geest, Lydia G., Wasser, Martin N.J.M., Feshtali, Shirin, Mieog, J. Sven D., Luelmo, Saskia A.C., Morreau, Hans, Potjer, Thomas P., Inderson, Akin, Boonstra, Jurjen J., Vasen, Hans F.A., van Hooft, Jeanin E., Bonsing, Bert A., van Leerdam, Monique E.

“…Recent pancreatic cancer surveillance programs of high-risk individuals have reported improved outcomes. This study assessed to what extent outcomes of…”
Get full text

Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease by Klatte, Derk C.F, Gasparini, Alessandro, Xu, Hong, de Deco, Pietro, Trevisan, Marco, Johansson, Anna L.V, Wettermark, Björn, Ärnlöv, Johan, Janmaat, Cynthia J, Lindholm, Bengt, Dekker, Friedo W, Coresh, Josef, Grams, Morgan E, Carrero, Juan J

“…Abstract Background & Aims Proton pump inhibitors (PPI) have been associated with acute kidney injury (AKI) and recent studies suggest that they may be…”
Get full text

Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma by Klatte, Derk C.F., Weston, Alexander, Ma, Yaohua, Sledge, Hanna, Bali, Aman, Bolan, Candice, Engels, Megan, van Hooft, Jeanin E., van Leerdam, Monique E., Ouni, Ahmed, Wallace, Michael B., Bi, Yan

“…Changes in body composition and metabolic factors may serve as biomarkers for the early detection of pancreatic ductal adenocarcinoma (PDAC). The aim of this…”
Get full text

Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance by Onnekink, Anke M, Michiels, Nynke, Klatte, Derk C F, Oldenburg, Lotte, Mieog, J Sven D, Vahrmeijer, Alexander L, van Hooft, Jeanin E, van Leerdam, Monique E, Bonsing, Bert A

Get full text

Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study by Klatte, Derk C. F., Onnekink, Anke M., Hinnen, Chris, Doorn, Remco, Potjer, Thomas P., Leerdam, Monique E., Bleiker, Eveline M. A.

“…Individuals with a germline CDKN2A pathogenic variant (PV) are at high risk of developing melanoma and pancreatic cancer and are therefore offered…”
Get full text

Pancreatic cancer surveillance: Risk stratification of individuals with a germline CDKN2A pathogenic variant by Klatte, Derk C. F., Meziani, Jihane, Cahen, Djuna L., van Diepen, Merel, Bruno, Marco J., van Leerdam, Monique E.

“…Individuals carrying a germline CDKN2A pathogenic variant (PV) are at a high risk of developing pancreatic ductal adenocarcinoma. Risk stratification could…”
Get full text

Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma by Klatte, Derk C F, Starr, Jason S, Clift, Kristin E, Hardway, Heather D, van Hooft, Jeanin E, van Leerdam, Monique E, Potjer, Thomas P, Presutti, R John, Riegert-Johnson, Douglas L, Wallace, Michael B, Bi, Yan

“…Guidelines recommend germline genetic testing (GT) for patients with pancreatic ductal adenocarcinoma (PDAC). This study aims to evaluate the utilization and…”
Get more information

Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes by Klatte, Derk C.F., Clift, Kristin E., Mantia, Sarah K., Millares, Lindsey, Hoogenboom, Sanne A.M., Presutti, Richard J., Wallace, Michael B.

“…Capturing family history might be a valuable tool for identification of individuals at increased risk of pancreatic cancer, which would allow enrollment into…”
Get full text

Large-scale multi-center CT and MRI segmentation of pancreas with deep learning by Zhang, Zheyuan, Keles, Elif, Durak, Gorkem, Taktak, Yavuz, Susladkar, Onkar, Gorade, Vandan, Jha, Debesh, Ormeci, Asli C., Medetalibeyoglu, Alpay, Yao, Lanhong, Wang, Bin, Isler, Ilkin Sevgi, Peng, Linkai, Pan, Hongyi, Vendrami, Camila Lopes, Bourhani, Amir, Velichko, Yury, Gong, Boqing, Spampinato, Concetto, Pyrros, Ayis, Tiwari, Pallavi, Klatte, Derk C.F., Engels, Megan, Hoogenboom, Sanne, Bolan, Candice W., Agarunov, Emil, Harfouch, Nassier, Huang, Chenchan, Bruno, Marco J., Schoots, Ivo, Keswani, Rajesh N., Miller, Frank H., Gonda, Tamas, Yazici, Cemal, Tirkes, Temel, Turkbey, Baris, Wallace, Michael B., Bagci, Ulas

“…Automated volumetric segmentation of the pancreas on cross-sectional imaging is needed for diagnosis and follow-up of pancreatic diseases. While CT-based…”
Get full text

Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study by Engels, Megan M.L., Berger, Calise K., Mahoney, Douglas W., Hoogenboom, Sanne A., Sarwal, Dhruv, Klatte, Derk C.F., De La Fuente, Jaime, Gandhi, Sonal, Taylor, William R., Foote, Patrick H., Doering, Karen A., Delgado, Adriana M., Burger, Kelli N., Abu Dayyeh, Barham K., Bofill-Garcia, Aliana, Brahmbhatt, Bhaumik, Chandrasekhara, Vinay, Gleeson, Ferga C., Gomez, Victoria, Kumbhari, Vivek, Law, Ryan J., Lukens, Frank J., Raimondo, Massimo, Rajan, Elizabeth, Storm, Andrew C., Vargas Valls, Eric J., van Hooft, Jeanin E., Wallace, Michael B., Kisiel, John B., Majumder, Shounak

“…In previous studies, methylated DNA markers (MDMs) have been identified in pancreatic juice (PJ) for detecting pancreatic ductal adenocarcinoma (PDAC). In this…”
Get full text

Large-Scale Multi-Center CT and MRI Segmentation of Pancreas with Deep Learning by Zhang, Zheyuan, Keles, Elif, Durak, Gorkem, Taktak, Yavuz, Susladkar, Onkar, Gorade, Vandan, Jha, Debesh, Ormeci, Asli C, Medetalibeyoglu, Alpay, Yao, Lanhong, Wang, Bin, Isler, Ilkin Sevgi, Peng, Linkai, Pan, Hongyi, Vendrami, Camila Lopes, Bourhani, Amir, Velichko, Yury, Gong, Boqing, Spampinato, Concetto, Pyrros, Ayis, Tiwari, Pallavi, Klatte, Derk C. F, Engels, Megan, Hoogenboom, Sanne, Bolan, Candice W, Agarunov, Emil, Harfouch, Nassier, Huang, Chenchan, Bruno, Marco J, Schoots, Ivo, Keswani, Rajesh N, Miller, Frank H, Gonda, Tamas, Yazici, Cemal, Tirkes, Temel, Turkbey, Baris, Wallace, Michael B, Bagci, Ulas

“…Automated volumetric segmentation of the pancreas on cross-sectional imaging is needed for diagnosis and follow-up of pancreatic diseases. While CT-based…”
Get full text